Evidence map›Paper›PMID 27876152›Full record

ArticleThe American journal of pathology2016

The Role of Substance P in Pulmonary Clearance of Bacteria in Comparative Injury Models.

Terry Hsieh, Max H Vaickus, Thor D Stein, Bethany L Lussier, Jiyoun Kim, David M Stepien, Elizabeth R Duffy, Evan L Chiswick, Daniel G Remick

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Terry HsiehDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Max H VaickusDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Thor D SteinDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts; VA Boston Healthcare System, Boston, Massachusetts; Department of Veterans Affairs Medical Center, Bedford, Massachusetts.
Bethany L LussierDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Jiyoun KimDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
David M StepienDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Elizabeth R DuffyDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Evan L ChiswickDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts.
Daniel G RemickDepartment of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts. Electronic address: remickd@bu.edu.
Boston University · US

Funding

BIOLOGY OF THE LUNG--MULTIDISCIPLINARY PROGRAMT32HL007035 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton, JOSEPH P MIZGERD · 1985 to 2026
$24.3M
RESEARCH TRAINING IN IMMUNOLOGYT32AI007309 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GUMMULURU, SURYARAM · 1988 to 2024
$7.4M
RESEARCH TRAINING IN BLOOD DISEASES AND RESOURCEST32HL007501 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LERNER, ADAM, STEINBERG, MARTIN H. · 1985 to 2018
$5.4M
Impact of Biological, Clinical, and Social Determinants on Trauma and Trauma OutcomesT32GM086308 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Alik Farber, Daniel G. Remick · 2010 to 2026
$3.5M
Role of Cytokines in Sepsis and TraumaR01GM082962 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI REMICK, DANIEL G. · 2009 to 2012
$1.3M
Adenosine and Oxygen Modulate Antimicrobial DefensesR01GM097320 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI REMICK, DANIEL G., SITKOVSKY, MICHAIL · 2011 to 2014
$1.2M
Mechanisms of phagocytic cell defects induced by inhibitory IgGR21AI112887 · NIAID · BOSTON UNIVERSITY MEDICAL CAMPUS · PI REMICK, DANIEL G. · 2014 to 2015
$450k
NHLBI NIH HHS T32 HL007035NHLBI NIH HHS T32 HL007501NIAID NIH HHS R21 AI112887NIAID NIH HHS T32 AI007309NIGMS NIH HHS R01 GM082962NIGMS NIH HHS R01 GM097320NIGMS NIH HHS T32 GM086308
6 · The paper itself

Abstract

Neural input to the immune system can alter its ability to clear pathogens effectively. Patients suffering mild traumatic brain injury (mTBI) have shown reduced rates of pneumonia and a murine model replicated these findings, with better overall survival of TBI mice compared with sham-injured mice. To further investigate the mechanism of improved host response in TBI mice, this study developed and characterized a mild tail trauma model of similar severity to mild TBI. Both mild tail trauma and TBI induced similar systemic changes that normalized within 48 hours, including release of substance P. Examination of tissues showed that injuries are limited to the target tissue (ie, tail in tail trauma, brain in mTBI). Pneumonia challenge showed that mild TBI mice showed improved immune responses, characterized by the following: i) increased survival, ii) increased pulmonary neutrophil recruitment, iii) increased bacterial clearance, and iv) increased phagocytic cell killing of bacteria compared with tail trauma. Administration of a neurokinin-1-receptor antagonist to block substance P signaling eliminated the improved survival of mTBI mice. Neurokinin-1-receptor antagonism did not alter pneumonia mortality in tail trauma mice. These data show that immune benefits of trauma are specific to mTBI and that tail trauma is an appropriate control for future studies aimed at elucidating the mechanisms of improved innate immune responses in mTBI mice.

Indexed as

AnimalsBacteriaBrain ConcussionDisease Models, AnimalFemaleHumansMiceMice, Inbred ICRNeurokinin-1 Receptor AntagonistsPneumoniaSignal TransductionSubstance PTailWounds and InjuriesNeurokinin-1 Receptor AntagonistsSubstance P

Identifiers

PMID27876152
PMCPMC5225288
OpenAlexW2552046790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.